| Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, F Byrne, M Cerrone, ... Nature cancer 2 (12), 1305-1320, 2021 | 165 | 2021 |
| Telemedicine during the COVID-19 pandemic: impact on care for rare cancers A Smrke, E Younger, R Wilson, O Husson, S Farag, E Merry, ... JCO global oncology 6, 1046-1051, 2020 | 108 | 2020 |
| Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer A Fendler, STC Shepherd, L Au, M Wu, R Harvey, AM Schmitt, Z Tippu, ... The Lancet 399 (10328), 905-907, 2022 | 77 | 2022 |
| Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, AM Schmitt, Z Tippu, ... Cancer Cell 40 (2), 114-116, 2022 | 66 | 2022 |
| Health-related quality of life and experiences of sarcoma patients during the COVID-19 pandemic E Younger, A Smrke, E Lidington, S Farag, K Ingley, N Chopra, ... Cancers 12 (8), 2288, 2020 | 61 | 2020 |
| Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients S Farag, N Somaiah, H Choi, B Heeres, WL Wang, H van Boven, ... European Journal of Cancer 76, 76-83, 2017 | 42 | 2017 |
| Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): The latest updates: Revolutions in treatment options in GIST S Farag, MJ Smith, N Fotiadis, A Constantinidou, RL Jones Current Treatment Options in Oncology 21, 1-11, 2020 | 40 | 2020 |
| Imatinib pharmacokinetics in a large observational cohort of gastrointestinal stromal tumour patients S Farag, RB Verheijen, J Martijn Kerst, A Cats, ADR Huitema, N Steeghs Clinical pharmacokinetics 56, 287-292, 2017 | 40 | 2017 |
| A single digital droplet PCR assay to detect multiple KIT exon 11 mutations in tumor and plasma from patients with gastrointestinal stromal tumors PA Boonstra, A Ter Elst, M Tibbesma, LJ Bosman, R Mathijssen, F Atrafi, ... Oncotarget 9 (17), 13870, 2018 | 37 | 2018 |
| Pleural pressure swing and lung expansion after malignant pleural effusion drainage: the benefits of high-temporal resolution pleural manometry RC Boshuizen, M Sinaasappel, AD Vincent, V Goldfinger, S Farag, ... Journal of bronchology & interventional pulmonology 20 (3), 200-205, 2013 | 36 | 2013 |
| Early evaluation of response using 18F-FDG PET influences management in gastrointestinal stromal tumor patients treated with neoadjuvant imatinib S Farag, LF de Geus-Oei, WT Van Der Graaf, F Van Coevorden, ... Journal of Nuclear Medicine 59 (2), 194-196, 2018 | 27 | 2018 |
| Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry AM Jackson, MC Petrie, A Frogoudaki, C Laroche, F Gustafsson, ... European journal of heart failure 23 (12), 2058-2069, 2021 | 25 | 2021 |
| Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity–a retrospective multicentre study in a … S Farag, F van Coevorden, E Sneekes, DJ Grunhagen, AKL Reyners, ... European journal of cancer 86, 318-325, 2017 | 25 | 2017 |
| Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer A Fendler, STC Shepherd, L Au, M Wu, R Harvey, KA Wilkinson, ... Cell Reports Medicine 3 (10), 2022 | 22 | 2022 |
| Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre F Chamberlain, S Farag, C Williams-Sharkey, C Collingwood, L Chen, ... Clinical sarcoma research 10, 1-8, 2020 | 22 | 2020 |
| Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation … S Farag, LE Van der Kolk, HH van Boven, ACJ van Akkooi, GL Beets, ... Familial Cancer 17, 247-253, 2018 | 13 | 2018 |
| Surgical and medical management of small bowel gastrointestinal stromal tumors: A report of the Dutch GIST registry PA Boonstra, N Steeghs, S Farag, F van Coevorden, H Gelderblom, ... European Journal of Surgical Oncology 45 (3), 410-415, 2019 | 9 | 2019 |
| Imatinib‐induced agranulocytosis in patients with gastrointestinal stromal tumors S Farag, AJ Verschoor, JW Bosma, H Gelderblom, JM Kerst, S Sleijfer, ... The Journal of Clinical Pharmacology 55 (8), 920-925, 2015 | 7 | 2015 |
| A retrospective multi-institutional cohort analysis of clinical characteristics and outcomes in dedifferentiated chondrosarcoma N Bui, H Dietz, S Farag, AC Hirbe, MJ Wagner, BA Van Tine, K Ganjoo, ... Cancers 15 (9), 2617, 2023 | 6 | 2023 |
| Telemedicine during the COVID-19 pandemic: impact on care for rare cancers. JCO Glob Oncol 6: 1046–1051 A Smrke, E Younger, R Wilson, O Husson, S Farag, E Merry, ... | 6 | 2020 |
